Company profile for Bio-Techne

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and cell and gene therapy workflow solutions including T-Cell activation technologies. Bio-Techne’s portfolio also includes protein analysis solutions, sold ...
Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and cell and gene therapy workflow solutions including T-Cell activation technologies. Bio-Techne’s portfolio also includes protein analysis solutions, sold under the ProteinSimple brand name, that offer researchers efficient and streamlined options for automated Western blot and multiplexed ELISA workflow.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
614 McKinley Place NE Minneapolis, MN 55413
Telephone
Telephone
612 379 2956
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/bio-techne-to-present-at-upcoming-investor-conferences-302625027.html

PR NEWSWIRE
25 Nov 2025

https://www.businesswire.com/news/home/20251125267575/en/Court-Finds-That-Two-Advanced-Cell-Diagnostics-Patents-Are-Not-Infringed-by-Molecular-Instruments-Proprietary-HCR-RNA-ISH-Technology

BUSINESSWIRE
25 Nov 2025

https://www.prnewswire.com/news-releases/ai-powered-spatial-biology-workflow-from-bio-techne-and-nucleai-enables-predictive-biomarker-discovery-in-melanoma-patients-302604119.html

PR NEWSWIRE
04 Nov 2025

https://www.contractpharma.com/breaking-news/sonoma-biotherapeutics-awarded-scaleready-g-rex-grant/

CONTRACTPHARMA
03 Nov 2025

https://www.pharmiweb.com/press-release/2025-10-15/saguaro-biosciences-partners-with-bio-techne-to-distribute-innovative-live-cell-imaging-reagents

PHARMIWEB
15 Oct 2025

https://www.prnewswire.com/news-releases/bio-techne-advances-spatial-biology-solutions-bridging-translational-research-to-clinical-applications-302568115.html

PR NEWSWIRE
26 Sep 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty